Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Michael Collins, MBChB, FRACP, PhD, a kidney transplant specialist at the Royal Adelaide Hospital, discusses his research on improving kidney transplant outcomes. He explains that during organ donation,…
Edward P.K. Kwakyi, BSc, and Rasheed A. Gbadegesin, MBBS, MD, FASN, discuss the role of apolipoprotein L1 (APOL1) in kidney diseases, particularly in people of African ancestry. APOL1…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses the treatment of large kidney tumors. Historically, most kidney cancers presented as large masses, but with advancements in…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
Rajiv Agarwal, MD, BS, a renowned nephrology expert, discusses the importance of early detection and treatment of chronic kidney disease (CKD), particularly in patients with type 2 diabetes.…
Surya Seshan, MBBS, of New York-Presbyterian Hospital and Weill Cornell Medical College, discusses the basics of antiphospholipid antibody syndrome, first described by Professor Hughes in the 1980s. The…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses renal cysts. These are very common, especially in individuals over the age of 50, and are usually asymptomatic.…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, highlights that CKD is more common than realized, affecting about 37 million adults in the US, but 90% may not be…
Majd Isreb, MD, FACP, FASN, IFMCP, from the Integrative Kidney Institute, discusses the link between inflammation and chronic kidney disease (CKD). He explains that CKD patients have higher…
This webinar snippet features Neera Dahl, MD, PhD, professor of medicine, medical director of nephrology, and director of the Nephrology Clinical Trials Program at Yale School of Medicine,…
